Patient-Centered Market Access

Focus on what matters: patient outcomes

Through therapeutic guidelines, tight management of access, and control on pricing, payers have become a major stakeholder in commercialization. There is increasing pressure to establish the clinical value of medical products based on endpoints that are meaningful, i.e., patient outcomes. The growing number of payer/pharma deals also calls for measuring real life outcomes in the targeted population.

Related services:

Foster a unified endpoint strategy for labeling and access
Design outcome strategies to ensure that the relevant data will be presented to establish clinical value and gain optimal formulary placement and reimbursement
Develop clinical outcome assessment strategies for real world studies to establish burden, impact on resource utilization, and additional evidence of effectiveness
Determine relevant outcomes in targeted population to measure the performance of risk-sharing agreements
Design outcome programs for life-cycle management

TwoLegs Consulting

Change the Paradigm // Start with the Patient

Patient-Centered Market Access

Like this: